Cerus (CERS) Accounts Payables (2010 - 2026)
Cerus (CERS) reported Accounts Payables of $31.8 million for Q1 2026, up 14.86% on a YoY basis from $27.7 million in Q1 2025, and up 13.5% sequentially from $28.0 million in Q4 2025.
Cerus (CERS) Accounts Payables (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Accounts Payables data on file, last reported at $31.8 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 14.86% year-over-year to $31.8 million; the trailing twelve-month figure through Mar 2026 stood at $31.8 million (up 14.86% YoY), and the FY2025 full-year result was $28.0 million, up 29.1% from the prior year.
- Accounts Payables rose to $31.8 million in Q1 2026, from $28.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $38.5 million in Q3 2023 to a low of $15.9 million in Q3 2024.
- A 5-year average of $27.9 million and a median of $29.4 million in 2022 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables sank 58.82% in 2024 and jumped 82.32% in 2025, its largest moves.
- Tracing CERS's Accounts Payables over 5 years: stood at $33.0 million in 2022, then fell by 27.76% to $23.8 million in 2023, then dropped by 9.01% to $21.7 million in 2024, then gained by 29.1% to $28.0 million in 2025, then climbed by 13.5% to $31.8 million in 2026.
- Business Quant data shows CERS's Accounts Payables at $31.8 million in Q1 2026, $28.0 million in Q4 2025, and $25.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 3.41 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 1.18 Bn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 2.33 Bn |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn | 31.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.79 Mn |
| Dec 31, 2025 | 28.01 Mn |
| Sep 30, 2025 | 25.47 Mn |
| Jun 30, 2025 | 30.52 Mn |
| Mar 31, 2025 | 27.68 Mn |
| Dec 31, 2024 | 21.70 Mn |
| Sep 30, 2024 | 15.86 Mn |
| Jun 30, 2024 | 16.74 Mn |
| Mar 31, 2024 | 16.62 Mn |
| Dec 31, 2023 | 23.84 Mn |
| Sep 30, 2023 | 38.52 Mn |
| Jun 30, 2023 | 37.49 Mn |
| Mar 31, 2023 | 36.44 Mn |
| Dec 31, 2022 | 33.00 Mn |
| Sep 30, 2022 | 29.82 Mn |
| Jun 30, 2022 | 29.36 Mn |
| Mar 31, 2022 | 31.47 Mn |
| Dec 31, 2021 | 35.61 Mn |
| Sep 30, 2021 | 26.19 Mn |
| Jun 30, 2021 | 30.89 Mn |